Source: Annual Congress 2001 - Treatment modalities and outcome in chronic respiratory care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Kastelik, J. C. Ojoo, I. Aziz, A. E. Redington, L. M. Burkinshaw, A. H. Morice (Hull, United Kingdom). Compliance with nebulized therapy in patients with chronic lung disease. Eur Respir J 2001; 16: Suppl. 31, 474

Member's Comments

No comment yet.

Related content which might interest you: Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003 Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008 Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Efficacy of pulmonary rehabilitation in patients with interstitial lung disease Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 The effect preoperative intervention with long-acting bronchodilator for untreated patients with obstructive lung disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 Triple therapy with Fluticasone furoate/Umeclidinium/Vilanterol compared with dual bronchodilation or triple therapy with inhaled corticosteroids/dual bronchodilation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Formoterol turbuhaler is an effective maintenance and maintenance plus reliever therapy in patients with chronic obstructive pulmonary disease (COPD) irrespective of the level of lung function impairment and reversibility Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002